Siloam International Hospitals (SILO)
Jakarta Exchange · Indonesia · prices in IDR · close of 19 Oct 2026
Key indicators
| Last close | IDR 1,760.00 |
|---|---|
| 52-week range | 1,595.00 – 2,880.00 |
| Return, 1 month / 3 months | −10.2% / −16.2% |
| Return, 1 year / 3 years | −6.4% / −6.4% |
| Trend | Below its 200-day average |
| RSI (14) | 27 |
| Volatility (1 year) | 37.4% |
| Worst drawdown (1 year) | -39.4% |
| Average daily value traded | 2,163.90M IDR |
| Dividend yield | – |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
Siloam International Hospitals runs a network of private hospitals in Indonesia, offering general and specialist medical care to patients in cities across the country. Its hospitals provide services such as emergency care, surgery, diagnostics, maternity care and outpatient treatment, supported by doctors and medical staff. The company is based in Indonesia and serves local patients as well as people seeking private healthcare, with facilities in several urban areas including the capital region.
The shares are listed on the Jakarta Exchange in Indonesia under the code SILO, and the price on this page is in Indonesian rupiah (IDR). Our dividend records, which start in 2019, show payments in 4 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
Siloam International Hospitals (SILO) trades on the Jakarta Exchange in Indonesia. It last closed at IDR 1,760.00 on 19 October 2026.
Its price-based Market X-Ray is 56 out of 100 (a fair price profile), ranking 377 of 923 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price fell 6.4% and over the last three months it fell 16.2%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on Jakarta Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 42 · Weak | Below its long-term averages and far from its highs. | |
| Above 200-day average | -25.8% | ||
| From 52-week high | -38.9% | ||
| Momentum | 46 · Weak | Lagging most stocks on this exchange. | |
| 3-month return | -16.2% | ||
| 6-month return | -29.0% | ||
| 12-month return, skipping the last month | 4.3% | ||
| Risk (lower is better) | 75 · Strong | Calmer than most: low volatility and shallow drawdowns. | |
| Volatility (1 year) | 37.4% | ||
| Worst drawdown (1 year) | -39.4% | ||
| Liquidity | 62 · Fair | Moderate trading activity. | |
| Average daily value traded | 2,163.90M IDR | ||
| Zero-volume days | 3.3% | ||
| Income | – | Pays no dividend. | |
| Dividend yield | – | ||
| Years with dividends | 3 |
Strengths
- Risk (lower is better): Calmer than most: low volatility and shallow drawdowns.
Weak spots
- Trend: Below its long-term averages and far from its highs.
- Momentum: Lagging most stocks on this exchange.
Returns
| 1 week | −7.4% |
|---|---|
| 1 month | −10.2% |
| 3 months | −16.2% |
| 6 months | −29.0% |
| 1 year | −6.4% |
| 3 years | −6.4% |
| 5 years | – |
Signals
| 50-day / 200-day average | 2,079.40 / 2,372.58 |
|---|---|
| Golden / death cross (60 days) | None |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 76.65 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 10 Jun 2024 | IDR 20.0000 |
| 7 Jun 2023 | IDR 19.6700 |
| 10 Jun 2022 | IDR 19.3000 |
| 7 May 2021 | IDR 139.0000 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on Jakarta Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.